ACADIA Pharmaceuticals: Nuplazid And Daybue Are Enough To Remain Bullish
ACADIA Pharmaceuticals(US:ACAD) Seeking Alphaยท2025-10-06 11:30Company Overview - ACADIA Pharmaceuticals Inc. is a biopharma firm listed on NASDAQ under the ticker ACAD, with a portfolio that includes two commercial drugs: Nuplazid and Daybue [1] Product Details - Nuplazid is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP) [1] - Daybue is indicated for the treatment of Rett syndrome [1]